141 related articles for article (PubMed ID: 21918545)
1. Suicidal gene therapy in the effective control of primary human hepatocellular carcinoma as monitored by noninvasive bioimaging.
Sia KC; Huynh H; Chinnasamy N; Hui KM; Lam PY
Gene Ther; 2012 May; 19(5):532-42. PubMed ID: 21918545
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive and real-time monitoring of the therapeutic response of tumors in vivo with an optimized hTERT promoter.
Yu ST; Li C; Lü MH; Liang GP; Li N; Tang XD; Wu YY; Shi CM; Chen L; Li CZ; Cao YL; Fang DC; Yang SM
Cancer; 2012 Apr; 118(7):1884-93. PubMed ID: 22009660
[TBL] [Abstract][Full Text] [Related]
3. In vivo preclinical low-field MRI monitoring of tumor growth following a suicide-gene therapy in an orthotopic mice model of human glioblastoma.
Breton E; Goetz C; Kintz J; Accart N; Aubertin G; Grellier B; Erbs P; Rooke R; Constantinesco A; Choquet P
C R Biol; 2010 Mar; 333(3):220-5. PubMed ID: 20338540
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy for human hepatocellular carcinoma with cytosine deaminase gene and prodrug flucytosine.
Lü HZ; Wu DZ; Wan YL; Gu B; Gao HZ; Liang YQ; Wang JX
Zhongguo Yao Li Xue Bao; 1999 May; 20(5):440-4. PubMed ID: 10678093
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties.
Yi BR; Kim SU; Kim YB; Lee HJ; Cho MH; Choi KC
Oncol Rep; 2012 Jun; 27(6):1823-8. PubMed ID: 22426744
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated cytosine deaminase/5-fluorocytosine suicide gene therapy of human hepatoblastoma in vitro.
Warmann SW; Armeanu S; Heigoldt H; Ruck P; Vonthein R; Heitmann H; Seitz G; Lemken ML; Bitzer M; Fuchs J; Lauer UM
Pediatr Blood Cancer; 2009 Aug; 53(2):145-51. PubMed ID: 19213079
[TBL] [Abstract][Full Text] [Related]
8. Replicating retroviral vectors for oncolytic virotherapy of experimental hepatocellular carcinoma.
Lu YC; Chen YJ; Yu YR; Lai YH; Cheng JC; Li YF; Shen CH; Tai CK
Oncol Rep; 2012 Jul; 28(1):21-6. PubMed ID: 22552490
[TBL] [Abstract][Full Text] [Related]
9. The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model.
Nyati MK; Symon Z; Kievit E; Dornfeld KJ; Rynkiewicz SD; Ross BD; Rehemtulla A; Lawrence TS
Gene Ther; 2002 Jul; 9(13):844-9. PubMed ID: 12080378
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.
Xie Y; Gilbert JD; Kim JH; Freytag SO
Clin Cancer Res; 1999 Dec; 5(12):4224-32. PubMed ID: 10632364
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
Akbulut H; Zhang L; Tang Y; Deisseroth A
Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
[TBL] [Abstract][Full Text] [Related]
12. Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes.
Hajri A; Wack S; Lehn P; Vigneron JP; Lehn JM; Marescaux J; Aprahamian M
Cancer Gene Ther; 2004 Jan; 11(1):16-27. PubMed ID: 14681723
[TBL] [Abstract][Full Text] [Related]
13. 5-Fluorocytosine increases the toxicity of Wnt-targeting replicating adenoviruses that express cytosine deaminase as a late gene.
Fuerer C; Iggo R
Gene Ther; 2004 Jan; 11(2):142-51. PubMed ID: 14712298
[TBL] [Abstract][Full Text] [Related]
14. Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice.
Gnant MF; Puhlmann M; Alexander HR; Bartlett DL
Cancer Res; 1999 Jul; 59(14):3396-403. PubMed ID: 10416601
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus.
Foloppe J; Kintz J; Futin N; Findeli A; Cordier P; Schlesinger Y; Hoffmann C; Tosch C; Balloul JM; Erbs P
Gene Ther; 2008 Oct; 15(20):1361-71. PubMed ID: 18480846
[TBL] [Abstract][Full Text] [Related]
16. Targeted chemotherapy for head and neck cancer with a chimeric oncolytic adenovirus coding for bifunctional suicide protein FCU1.
Dias JD; Liikanen I; Guse K; Foloppe J; Sloniecka M; Diaconu I; Rantanen V; Eriksson M; Hakkarainen T; Lusky M; Erbs P; Escutenaire S; Kanerva A; Pesonen S; Cerullo V; Hemminki A
Clin Cancer Res; 2010 May; 16(9):2540-9. PubMed ID: 20388844
[TBL] [Abstract][Full Text] [Related]
17. Suicide gene therapy of hepatocellular carcinoma and delivery procedure and route of therapeutic gene in vivo.
Sun XY; Wu ZD; Hu JB
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):373-7. PubMed ID: 14607709
[TBL] [Abstract][Full Text] [Related]
18. [Study on the in vivo killing activity of YCD/5-FC gene therapy system on K562B cells].
Zhang Y; Wang J; Zhou H; Zhai Y
Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):173-5. PubMed ID: 12133450
[TBL] [Abstract][Full Text] [Related]
19. Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control.
Mathis JM; Williams BJ; Sibley DA; Carroll JL; Li J; Odaka Y; Barlow S; Nathan CO; Li BD; DeBenedetti A
J Gene Med; 2006 Sep; 8(9):1105-20. PubMed ID: 16802401
[TBL] [Abstract][Full Text] [Related]
20. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]